Submission for OMB Review; Comment Request; Outcome Evaluation of the Small Grants Program for Behavioral Research in Cancer Control, 17096-17097 [05-6604]
Download as PDF
<![CDATA[
17096
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB number.
Proposed Collection: Title: Survey of
Colorectal Cancer Screening Policies,
Programs, and Systems in U.S. Health
Plans. Type of Information Collection
Request: New. Need and Use of
Information Collection: This study will
obtain information on policies,
programs, and practices for colorectal
cancer screening among health plans in
the U.S. The purpose of the study is to
assess (1) health plan policies,
programs, and practices for colorectal
cancer screening; (2) health plan
activities in response to the National
Committee on Quality Assurance’s new
Health Employer Data Information Set
measure for colorectal cancer screening;
and (3) characteristics of health plans
and plan policies and activities that may
be associated with higher rates of
colorectal cancer screening. A
questionnaire will be administered by
mail or Internet using a national sample
of health plans. Study participants will
be health plan medical directors or
administrators, and they will select their
preferred response mode. Burden
estimates are as follows:
Type of respondents
Estimated
number
respondents
Estimated
number
responses per
respondent
Average
burden hours
per response
Estimated total
annual burden
hours
Health plan medical directors ..........................................................................
400
1
0.333
133
Request For Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the
performance of the functions of the
agency, including whether the
information shall have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (3) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Direct Comments To OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, New Executive
Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Carrie
N. Klabunde, Ph.D., Epidemiologist,
National Cancer Institute, EPN 4005,
6130 Executive Boulevard, Bethesda,
Maryland 20892–7344. Telephone: (301)
402–3362; e-mail: ck97b@nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
Dated: March 21, 2005.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 05–6603 Filed 4–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; Outcome
Evaluation of the Small Grants
Program for Behavioral Research in
Cancer Control
SUMMARY: Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the (National
Cancer Institute), the National Institutes
of Health has submitted to the Office of
Management and Budget (OMB) a
request to review and approve the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on August 31, 2004, page 53079
and allowed 60 days for public
comment. No public comment was
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Proposed Collection: Title: Outcome
Evaluation of the Small Grants Program
for Behavioral Research in Cancer
Control. Type of Information Collection
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Request: New. Need and Use of
Information Collection: The Small
Grants Program support projects that
can be completed in a short period of
time, such as pilot projects,
development and testing of new
methodologies, secondary data analyses,
or innovative studies that provide a
basis for more extended research. This
evaluation is being conducted to
identify progress of this program in
establishing a cohort of scientists with
a high level of research expertise in
behavioral research cancer control. A
primary objective of this study is to
determine if the program’s small grants
R03 funding mechanism is effective in
attracting investigators to the field of
behavioral research and if so, what
impact does the program have on the
career of successful applicants. The
findings will provide valuable
information regarding (1) effectiveness
of the program in attracting investigators
to the field; (2) the impact of the
program on investigators careers; and (3)
the overall benefit provided by the
program through the R03 funding
mechanism and assist the agency in
determining whether changes to the
program are necessary in future.
Frequency of Response: On occasion.
Affected Public: Individuals; teaching
institutions or other non-profit. Type of
Respondents: Grantees funded under
PAR 99–006 (n = 80). Type of
Respondents: Principal Investigator
awarded grants funded by PAR 00–006
(Dec. 1999–Nov. 2001); Estimated
Number of Respondents: 80; Estimated
Number of Response Per Respondent: 1;
Average Burden Hours Per Response:
75; and Estimated Total Annual Burden
Hours Requested: 60.
E:\FR\FM\04APN1.SGM
04APN1
17097
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
Estimated
number of
responses per
respondent
Estimated
number of
respondents
Type of respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Principal Investigators awarded grants funded by PAR 99–006 (Dec. 1999–
Nov. 2001) ....................................................................................................
80
1
0.75
60.0
Total ..........................................................................................................
........................
........................
........................
60.0
There is no cost to respondents. There
are no Capital Costs to report. There are
no Operating or Maintenance Costs to
report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
those who are able to respond,
including the use of appropriate
automated, electronic, mechanical, or
other technological collection
techniques or other forms of information
technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, New Executive
Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Veronica
Chollette, RN, MS Program Director,
Applied Cancer Screening Research
Branch, Behavioral Research Program
Division of Cancer Control and
Population Sciences, National Cancer
Institute, 6130 Executive Blvd., Room
4100, Rockville, MD 20852 or call nontoll free number 301–435–2837 or email your request to: vc24a@nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
Dated: March 21, 2005.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 05–6604 Filed 4–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, DHHS.
ACTION: Notice.
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: (301)
496–7057; fax: (301) 402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Biomarkers for Tissue Status
Joseph Riss and J. Carl Barrett (NCI).
U.S. Provisional Application No. 60/
649,208 filed 01 Feb 2005 (DHHS
Reference No. E–064–2005/0–US–01).
Licensing Contact: Thomas P. Clouse;
(301) 435–4076; clouset@mail.nih.gov.
Certain biomarkers are differentially
expressed in various tissue samples,
including those of renal cancer and in
kidney ischemia/reperfusion. The
technology relates to methods of quickly
and accurately diagnosing and
monitoring progression of cancer and
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
ischemically-injured tissue. The
technology provides sensitive diagnostic
and therapeutic methods using
identified biomarkers associated with
RCC, acute renal failure, renal
regeneration and repair (RRR), organ
transplantation and shipment, wound
healing, tumors, and organ failure. The
potential market for diagnostics and
therapeutics in this area is substantial.
For example, Renal Cell Carcinoma
(RCC) accounts for three (3) percent of
all adult male malignancies in the
United States. Patent protection for this
technology is pending.
In addition to licensing, the
technology is available for further
development through collaborative
research opportunities with the
inventors.
Methods of Diagnosing and Treating
VHL Associated and Sporadic Renal
Cell Carcinoma, and Other VHL
Associated and Sporadic Counterpart
Tumors Which Co-Express Epo and the
Epo Receptor
Zhengping Zhuang et al. (NINDS).
U.S. Provisional Application No. 60/
611,616 filed 20 Sep 2004 (DHHS
Reference No. E–274–2004/0–US–01).
Licensing Contact: Thomas P. Clouse;
(301) 435–4076; clouset@mail.nih.gov.
While von Hippel-Lindau (VHL) gene
germline mutations have been identified
as the cause of tumors in VHL patients,
the link between gene mutation and
tumor development has remained
unclear, e.g., it is unknown why only
selected organs and cell types are
affected. The inventors have discovered
that EPO and EPOR are co-expressed in
tumors of VHL patients. The coexpression of the EPO and EPO-receptor
is also related to the tumor growth and
progression in sporadic renal tumors
and tumors in kidney dialysis patients.
Since the co-expression of EPO and
EPOR are not present in most normal
adult tissues, ligands that bind to EPOR
but do not activate the receptor can
target specific tumor cells with minimal
detrimental effect on normal cells.
In addition to licensing, the
technology is available for further
development through collaborative
research opportunities with the
inventors.
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 70, Number 63 (Monday, April 4, 2005)]
[Notices]
[Pages 17096-17097]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; Outcome Evaluation of
the Small Grants Program for Behavioral Research in Cancer Control
SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the (National Cancer Institute), the National
Institutes of Health has submitted to the Office of Management and
Budget (OMB) a request to review and approve the information collection
listed below. This proposed information collection was previously
published in the Federal Register on August 31, 2004, page 53079 and
allowed 60 days for public comment. No public comment was received. The
purpose of this notice is to allow an additional 30 days for public
comment. The National Institutes of Health may not conduct or sponsor,
and the respondent is not required to respond to, an information
collection that has been extended, revised, or implemented on or after
October 1, 1995, unless it displays a currently valid OMB control
number.
Proposed Collection: Title: Outcome Evaluation of the Small Grants
Program for Behavioral Research in Cancer Control. Type of Information
Collection Request: New. Need and Use of Information Collection: The
Small Grants Program support projects that can be completed in a short
period of time, such as pilot projects, development and testing of new
methodologies, secondary data analyses, or innovative studies that
provide a basis for more extended research. This evaluation is being
conducted to identify progress of this program in establishing a cohort
of scientists with a high level of research expertise in behavioral
research cancer control. A primary objective of this study is to
determine if the program's small grants R03 funding mechanism is
effective in attracting investigators to the field of behavioral
research and if so, what impact does the program have on the career of
successful applicants. The findings will provide valuable information
regarding (1) effectiveness of the program in attracting investigators
to the field; (2) the impact of the program on investigators careers;
and (3) the overall benefit provided by the program through the R03
funding mechanism and assist the agency in determining whether changes
to the program are necessary in future. Frequency of Response: On
occasion. Affected Public: Individuals; teaching institutions or other
non-profit. Type of Respondents: Grantees funded under PAR 99-006 (n =
80). Type of Respondents: Principal Investigator awarded grants funded
by PAR 00-006 (Dec. 1999-Nov. 2001); Estimated Number of Respondents:
80; Estimated Number of Response Per Respondent: 1; Average Burden
Hours Per Response: 75; and Estimated Total Annual Burden Hours
Requested: 60.
[[Page 17097]]
----------------------------------------------------------------------------------------------------------------
Estimated Average
Estimated number of burden per Total burden
Type of respondents number of responses per response (in (in hours)
respondents respondent hours)
----------------------------------------------------------------------------------------------------------------
Principal Investigators awarded grants funded by 80 1 0.75 60.0
PAR 99-006 (Dec. 1999-Nov. 2001)...............
-----------------
Total....................................... .............. .............. .............. 60.0
----------------------------------------------------------------------------------------------------------------
There is no cost to respondents. There are no Capital Costs to
report. There are no Operating or Maintenance Costs to report.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility; (2) the
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) ways to minimize
the burden of the collection of information those who are able to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, New Executive Office Building, Room 10235, Washington, DC
20503, Attention: Desk Officer for NIH. To request more information on
the proposed project or to obtain a copy of the data collection plans
and instruments, contact Veronica Chollette, RN, MS Program Director,
Applied Cancer Screening Research Branch, Behavioral Research Program
Division of Cancer Control and Population Sciences, National Cancer
Institute, 6130 Executive Blvd., Room 4100, Rockville, MD 20852 or call
non-toll free number 301-435-2837 or e-mail your request to:
vc24a@nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
Dated: March 21, 2005.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 05-6604 Filed 4-1-05; 8:45 am]
BILLING CODE 4140-01-M
